Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Patent
1993-10-13
1996-01-16
Venkat, Jyothsna
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
424451, 424461, 424468, 424478, 424480, A61K 964, A61K 962, A61K 940
Patent
active
054846072
ABSTRACT:
A method of providing a patient needing clonidine with an extended dosage of clonidine over a prolonged period of time. Such method involves administering to the patient an oral dosage unit comprising a homogenous mixture of a therapeutically effective amount of clonidine, about 30 to about 70 percent by weight of one or more cellulose ethers such as hydroxypropyl methylcellulose, and about 30 to about 70 percent by weight of an inert substance such as cornstarch. The oral dosage unit may be contained in a gelatin capsule or in the form of a tablet.
REFERENCES:
patent: 3870790 (1975-03-01), Lowey et al.
patent: 4094964 (1978-06-01), Jarrott et al.
patent: 4167558 (1979-09-01), Sheth et al.
patent: 4201211 (1980-05-01), Chandrasekaran et al.
patent: 4226849 (1980-10-01), Schor
patent: 4259314 (1981-03-01), Lowey
patent: 4279928 (1981-07-01), Riley et al.
patent: 4292303 (1981-09-01), Keith et al.
patent: 4312878 (1982-01-01), Redmond, Jr.
patent: 4312879 (1982-01-01), Lal
patent: 4357469 (1982-11-01), Schor
patent: 4369172 (1983-01-01), Schor et al.
patent: 4389393 (1983-06-01), Schor et al.
patent: 4505890 (1985-03-01), Jain et al.
patent: 4540566 (1985-09-01), Davis et al.
patent: 4556678 (1985-12-01), Hsiao
patent: 4578264 (1986-03-01), Stricker et al.
patent: 4587257 (1986-05-01), DeSantis et al.
patent: 4603141 (1986-07-01), Giles
patent: 4612008 (1986-09-01), Wong et al.
patent: 4680186 (1987-07-01), Sheehy et al.
patent: 4685918 (1987-08-01), Amidon et al.
patent: 4734285 (1988-03-01), Alderman
patent: 4785014 (1988-11-01), Goldman-Rakic et al.
patent: 4798725 (1989-01-01), Patel
patent: 4851228 (1989-07-01), Zentner et al.
patent: 4871548 (1989-10-01), Edgren et al.
patent: 4874613 (1989-10-01), Hsiao
patent: 4880632 (1989-11-01), Lipham et al.
patent: 4883649 (1989-11-01), Counsell et al.
patent: 4902515 (1990-02-01), Loomis et al.
patent: 4931281 (1990-06-01), Kim et al.
patent: 4946848 (1990-08-01), Tuttle et al.
patent: 4981696 (1991-01-01), Loomis et al.
patent: 4994260 (1991-02-01), Kallstrand et al.
patent: 5051262 (1991-09-01), Panoz et al.
patent: 5082668 (1992-01-01), Wong et al.
patent: 5133974 (1992-07-01), Paradissis et al.
patent: 5175052 (1992-12-01), Tokuda et al.
patent: 5178868 (1993-01-01), Malmqvist-Granlund et al.
patent: 5209746 (1993-05-01), Balaban et al.
patent: 5212162 (1993-05-01), Missel et al.
patent: 5212196 (1993-05-01), House et al.
patent: 5213808 (1993-05-01), Bar-Shalom et al.
patent: 5221278 (1993-06-01), Linkwitz et al.
Remington's Pharmaceutical Sciences pp. 1284, 1314-1315 (1985).
Clonidine in Child and Adolescent Psychiatry, Robert D. Hunt, M. D., Lisa Capper, B. S., and Patricia O'Connell, B. S., Journal of Child and Adolescent Psychopharmacology, vol. 1, No. 1, 1990, pp. 87-102.
Evans Richard W.
Johnston Michael G.
Venkat Jyothsna
LandOfFree
Extended release clonidine formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Extended release clonidine formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extended release clonidine formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-307945